Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression
- 1 July 2008
- journal article
- research article
- Published by Elsevier BV in Cell
- Vol. 134 (1), 62-73
- https://doi.org/10.1016/j.cell.2008.06.006
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- CD44+CD24− prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosisBritish Journal of Cancer, 2008
- Brca1 breast tumors contain distinct CD44+/CD24- and CD133+cells with cancer stem cell characteristicsBreast Cancer Research, 2008
- ΔNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neckThe Journal of Pathology, 2007
- Restoration of p53 function leads to tumour regression in vivoNature, 2007
- E6/E7 oncogenes increase and tumor suppressors decrease the proportion of self-renewing neural progenitor cellsOncogene, 2006
- An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survivalProceedings of the National Academy of Sciences, 2005
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences, 2003
- Serial analysis of gene expression in normal p53 null mammary epitheliumOncogene, 2002
- p130/E2F4 Binds to and Represses the cdc2 Promoter in Response to p53Published by Elsevier BV ,2001
- CD44 is the principal cell surface receptor for hyaluronateCell, 1990